Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis

INTRODUCTION: Hepatitis C virus (HCV) is the second major cause of death in Pakistan. Previously, interferon-based regimens were considered highly recommended therapy for HCV patients. Since 2015, interferon-based therapy has been replaced with interferon-free therapy also known as Direct Acting Ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Riaz, Hafiza Arooba, Nishwa, Dur E., Fatima, Ameer, Wahid, Braira, Ali, Akhtar, Kumari, Babita, Idrees, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205523/
https://www.ncbi.nlm.nih.gov/pubmed/37234654
http://dx.doi.org/10.1016/j.heliyon.2023.e16169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205523/
https://www.ncbi.nlm.nih.gov/pubmed/37234654
http://dx.doi.org/10.1016/j.heliyon.2023.e16169

Ejemplares similares